全覆膜自膨式金属支架与塑料支架治疗肝移植术后胆管吻合口狭窄的随机对照试验
单中心开放标签随机对照试验纳入64例 deceased 原位肝移植(OLT)术后胆管吻合口狭窄患者,1:1随机接受单根全覆膜自膨式金属支架(cSEMS)留置6个月或塑料支架(MPS)每3个月更换、持续1年。cSEMS组与MPS组狭窄缓解率分别为83.3%与96.5%(P=.19),狭窄复发率分别为32%与0%(P<.01),不良事件发生率分别为23.3%与6.4%(P<.01)。结论认为cSEMS与MPS在狭窄缓解方面相当,cSEMS可减少操作次数并对费用有正面影响,cSEMS治疗时长需进一步研究,所有患者应考虑行括约肌切开。
要点
- cSEMS组与MPS组狭窄缓解率分别为83.3%与96.5%,差异无统计学意义(P=.19)。
- cSEMS组狭窄复发率32%高于MPS组的0%(P<.01)。
- cSEMS组ERCP不良事件发生率23.3%高于MPS组的6.4%(P<.01),其中急性胰腺炎分别为13.3%与2.1%(P<.01)。
核心结论
- cSEMS与MPS在肝移植术后胆管吻合口狭窄缓解方面相当。
- cSEMS可减少操作次数并对费用有正面影响。
- cSEMS的治疗时长应进一步研究。
- 所有患者应考虑行括约肌切开。
研究设计与样本
- 单中心、开放标签、随机对照临床试验。
- 2009年10月至2014年1月评估162例肝移植术后胆道不良事件患者,其中64例前瞻性1:1随机分配至cSEMS组或MPS组。
- cSEMS组置入单根cSEMS留置6个月;MPS组置入塑料支架并每3个月更换,持续1年。
- 主要结局为狭窄缓解;失败或复发时考虑交叉治疗;次要结局为持续改善、并发症和死亡。
主要发现
- cSEMS组与MPS组技术成功率均为100%。
- cSEMS组与MPS组中位随访时间分别为36.4个月与32.9个月。
- 末次取支架时狭窄缓解率cSEMS组为83.3%,MPS组为96.5%(P=.19)。
- 狭窄复发率cSEMS组为32%,MPS组为0%(P<.01)。
- ERCP不良事件发生率cSEMS组为23.3%,MPS组为6.4%(P<.01);急性胰腺炎发生率cSEMS组为13.3%,MPS组为2.1%(P<.01)。
临床怎么用
- 作者结论认为cSEMS与MPS在狭窄缓解方面相当,cSEMS可减少操作次数并对费用有正面影响。
- 作者认为cSEMS的治疗时长应进一步研究。
- 作者建议所有患者应考虑行括约肌切开。
局限性
- cSEMS的治疗时长应进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Biliary anastomotic stricture occurs in 15% to 20% of patients after deceased orthotopic liver transplantation (OLT). It is usually treated endoscopically with multiple plastic stents (MPSs), although the use of fully covered self-expandable metal stents (cSEMSs) is emerging. This study aims to compare the efficacy and safety of cSEMSs versus MPSs in these patients. METHODS: A single-center, open-label, randomized clinical trial was performed. Patients were randomized to single cSEMSs for 6 months or to MPS placement, exchanged every 3 months over 1 year. The primary outcome was stricture resolution. Crossover therapy was considered for failure or recurrence. Secondary outcomes were sustained improvement, morbidity, and mortality. RESULTS: Between October 2009 and January 2014, 162 patients with post-OLT biliary adverse events were assessed for eligibility. Sixty-four were prospectively randomized (1:1) to cSEMSs or MPSs. Baseline characteristics were comparable. Technical success was 100%. Median follow-up was 36.4 and 32.9 months for the cSEMS and MPS groups, stricture resolution at last stent removal was achieved in 83.3% and 96.5% (P = .19), and stricture recurrence was observed in 32% and 0%, respectively (P < .01). Adverse events occurred in 23.3% and 6.4% of ERCPs in the cSEMS and MPS groups, respectively (P < .01), with 13.3% of acute pancreatitis in the cSEMS group and 2.1% in the MPS group (P < .01). CONCLUSIONS: cSEMSs were comparable with MPSs regarding post-OLT biliary anastomotic stricture resolution. cSEMSs allowed fewer procedures and had a positive effect on cost. Duration of treatment with cSEMSs should be further investigated. Sphincterotomy should be considered for all patients. (Clinical trial registration number: NCT 01148199.).
引用
- Martins FP, De Paulo GA, Contini MLC, et al. Metal versus plastic stents for anastomotic biliary strictures after liver transplantation: a randomized controlled trial. Gastrointest Endosc. 2017. PMID: 28455159. doi:10.1016/j.gie.2017.04.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。